Vaxcyte
PCVX
PCVX
60 hedge funds and large institutions have $1.85B invested in Vaxcyte in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.13% less ownership
Funds ownership: 74.29% → 74.16% (-0.13%)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
60
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$82.4M | |
| 2 | +$65.3M | |
| 3 | +$45.7M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$15.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.5M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$24.5M | |
| 3 | -$14.4M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$11.4M |
| 5 |
O
OrbiMed
New York
|
-$10.3M |